Related Experiment Videos

Phase II evaluation of 4'deoxydoxorubicin in advanced renal cell carcinoma

J A Kish¹, J F Ensley, M al-Sarraf

¹Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI 48201.

American Journal of Clinical Oncology

|February 1, 1990

Abstract:

4'Deoxydoxorubicin was evaluated in patients with advanced renal carcinoma. Only one partial remission was noted, and no significant cardiac toxicity was seen on serial evaluation of ejection fractions. Appropriate dose escalations were performed.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

Esophageal carcinoma advances in treatment results for locally advanced disease: review.

Annals of oncology : official journal of the European Society for Medical Oncology·2011

Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma.

The Cochrane database of systematic reviews·2006

Comparison of DNA content parameters in paired, fresh tissue pretreatment biopsies and surgical resections from squamous cell carcinoma of the head and neck.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2003

Locally advanced nasopharyngeal cancer.

Current treatment options in oncology·2002

Autoimmunity to the M(r) 32,000 subunit of replication protein A in breast cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2002

See all related articles